Surveillance of Healthcare-Associated Infections Rates in Hematology-Oncology Patients
Journal Title: Journal of Integrative Oncology - Year 2017, Vol 6, Issue 4
Abstract
Background: Healthcare-associated infections (HAIs) consist of a major cause of morbidity and mortality among patients with hematologic malignancies, resulting in high length of stay and healthcare costs. The aim of this study was to assess the HAIs rates in adult hematology-oncology patients. Patients and Methods: A prospective surveillance study was performed in a hematology-oncology unit in Athens, Greece. All patients who remained for ≥ 48 hours were studied. A standardized surveillance system based on the National Healthcare Safety Network of the Centers for Disease Control and Prevention was implemented. Results: During 1,156 patient-days, 16 of 85 patients acquired 20 HAIs resulting in an overall rate of 18.8% of patients or 17.3 HAIs per 1,000 patient-days. FUO rate was 42.5 per 1,000 patient-days with neutropenia. Most of HAIs was laboratory confirmed (80%) than clinically documented (20%). Central line-associated bloodstream infection was the most commonly encountered type of infection, accounting for 25% of all HAIs, followed by soft tissue infections (20%). The rates of neutropenia, blood transfusion and presence of central venous catheter were significantly greater among patients with HAI, compared with patients without HAI (p<0.05). The crude mortality rate for patients with and without HAI was 12.5% and 2.9%, respectively (p=0.234).The mean length of stay was statistically longer for patients with HAI compared with patients without HAI (29.6 ± 28.5 vs. 9.8 ± 6.8 days, p<0.001). Gram-negative bacteria were the most prevalent pathogens (73.3%). Conclusions: Our findings highlight the problem of HAIs in hematology-oncology patients and emphasize the importance of a comprehensive education program focused on evidence-based approaches for all healthcare workers and continuing active surveillance program, which will contribute to reducing the consequences of HAIs and improving patient safety.
Authors and Affiliations
Alkmena Kafazi, Christos Stylianou, Eleni Apostolopoulou, Athanasios Zwmas, Christina Aggeli, Eirini Papadaki, Panagiota Stefanitsi
Keywords
Related Articles
- EP ID EP348693
- DOI 10.4172/2329-6771.1000200
- Views 87
- Downloads 0
Reduction of Hepatotoxicity Induced by Doxorubicin
Doxorubicin (DOX) has been used in the treatment of variety of cancers but its administration is limited by a dosedependent toxicity. Its cytotoxic effects on malignant cells have shown an increase in the risk of cardiot...
Ovarian Function Suppression: Is it the Right Time to Jump the Gun?
Ovarian function suppression (OFS) an old endocrine therapy has been tested in premenopausal women with early breast cancer (EBC) but not widely accepted in modern practice. The question is re-addressed in recent big tri...
Omega-3 Fatty Acids and Cancer Prevention
A recent review has summarized the evidence that omega-3 fatty acids (FA) have potential in reducing the risk for a common form of cancer [1]. This editorial is a synopsis of that review covering the historical interest...
The Efficacy and Safety of Massage Therapy for Cancer Inpatients with Venous Thromboembolism
Background: Cancer patients have a 4 to 7 fold increase in the frequency of Venous Thromboembolism (VTE) during treatment and VTE is a common cause of death. Oncology massage has been traditionally contraindicated in pat...
Hormone Therapy in Breast Cancer: Where do We Stand?
Breast cancer is not only the most common malignancy but also the leading causes of cancer-related deaths in women worldwide. The management of breast cancer is subtype driven and determination of hormone receptor [HR] s...